Clinical Trial Update: The Study of Pegylated Liposomal Doxorubicin Contrast Epirubicin for the Treatment of Diffuse Large B-cell Lymphoma [NA]

View source ↗

Summary

This document notes a clinical trial studying pegylated liposomal doxorubicin in combination with epirubicin for diffuse large B-cell lymphoma. The trial status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Epirubicin (epirubicin)
• Pegylated liposomal doxorubicin (pegylated liposomal doxorubicin)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Diffuse Large B-cell Lymphoma | NA | Status: UNKNOWN